COMMUNIQUÉS West-GlobeNewswire

Foamix Pharmaceuticals Third Quarter Financial Results Conference Call & Webcast Scheduled for November 8

29/10/2018 - 13:00

REHOVOT, Israel, and BRIDGEWATER, N.J., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Physeon Receives Institutional Review Board Approval to Commence US "VIVA" Trial for Veinplicity

29/10/2018 - 13:00

Recent Clinical Study Indicated Device had a Dilatory Effect 38% Greater than other Common Approaches for Veins Targeted for IV Access. Other studies indicate a First IV Stick Success Much Greater Than the Standard of [...]

Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER

29/10/2018 - 13:00

STOUGHTON, Mass., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the publication of “Evaluation of the oral human abuse potential of Oxycodone DETERx ® formulation ( [...]

Eidos Therapeutics to Host Conference Call and Webcast to Discuss Phase 2 Clinical Trial Results

29/10/2018 - 13:00

SAN FRANCISCO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics , Inc. (Eidos) (Nasdaq:EIDX) today announced that management will host a conference call and webcast to discuss the results of its Phase 2 clinical [...]

Melinta Therapeutics Announces Positive Top-Line Results in Phase III Trial of Baxdela® (delafloxacin) for Treatment of CABP

29/10/2018 - 13:00

– Met primary endpoint of Early Clinical Response at 96 hours after the first dose – – Supplemental NDA expected to be filed with FDA in 1H 2019 – – Baxdela currently FDA approved for treatment of adult patients with [...]

TESARO Announces Achievement of ZEJULA Prostate Cancer Development Milestones by Janssen

29/10/2018 - 13:00

WALTHAM, Mass., Oct. 29, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced the achievement of development milestones that trigger an $18 million payment [...]

Protech Home Medical Announces Insider Subscriptions

29/10/2018 - 13:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CINCINNATI, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“ PHM ” or the “ Company ”) (TSXV: PHM), is [...]

Iovance Biotherapeutics to Host Melanoma Program Update Event for Analysts and Investors During SITC 2018

29/10/2018 - 13:00

SAN CARLOS, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]

Loop Industries Endorses the New Plastics Economy Global Commitment – Helping Keep Plastic in the Economy and Out of Nature

29/10/2018 - 13:00

MONTREAL, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq: LOOP), a leading technology innovator in sustainable plastic, today announced that it has joined leading global consumer brands, including [...]

HempAmericana Retires All Outstanding Convertible Debt

29/10/2018 - 13:00

NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is proud to announce the retirement of all outstanding convertible debt. As of the filing [...]

BrainStorm Announces Financial Results for the Third Quarter of 2018 and Provides a Corporate Update

29/10/2018 - 13:00

Highlights Scientific Advances and Continued Progress for NurOwn ® in ALS Towards U.S. FDA Approval; Following Successful FDA Pre-IND Meeting, BrainStorm will File an IND for NurOwn ® in a Second Clinical Indication [...]

XBiotech annonce de nouveaux brevets au troisième trimestre 2018

29/10/2018 - 12:38

Demande/ autorisation de brevets pour des traitements candidats de la Société destinés aux maladies cardiovasculaires, aux infections par staphylocoque doré et à sa technologie de découverte d’antibiotiques AUSTIN ( [...]

ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals

29/10/2018 - 12:33

ProQR receives exclusive worldwide license for IONIS-RHO-2.5 Rx , now QR-1123, for autosomal dominant retinitis pigmentosa (adRP), a rare inherited form of blindness with no approved therapy A first in human Phase 1/2 [...]

United States Department of Health and Human Services Publishes New HIV Treatment Guidelines Including Trogarzo®

29/10/2018 - 12:30

MONTREAL, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Trogarzo ® (ibalizumab-uiyk) injection is now included in the most recent version of the [...]

Le United States Department of Health and Human Services publie des directives de traitement du VIH incluant Trogarzo(MD)

29/10/2018 - 12:30

MONTRÉAL, 29 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que Trogarzo MD (ibalizumab-uiyk) injection fait maintenant partie des plus récentes directives de [...]

Kura Oncology to Report Third Quarter 2018 Financial Results

29/10/2018 - 12:30

SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]

VIVUS Adds Two New Members to the Board of Directors

29/10/2018 - 12:30

Karen Ferrell and Edward A. Kangas Expand VIVUS’ Board to Nine Members CAMPBELL, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today announced that [...]

Otonomy to Report Third Quarter 2018 Financial Results and Provide Corporate Update

29/10/2018 - 12:30

Webcast and Conference Call to be Held at 4:30 p.m. EST on November 5, 2018 SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of [...]

Marinus Pharmaceuticals Provides Business Update and Third Quarter 2018 Financial Results

29/10/2018 - 12:30

RADNOR, Pa., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy [...]